Biomarker For Colorectal Cancer Could Help In Deciding On Aspirin Treatment
The tumor necrosis factor in blood could be a possible biomarker for colorectal cancer, it has been found. Those with higher baseline levels of the TNF benefited by taking aspirin.
The tumor necrosis factor in blood could be a possible biomarker for colorectal cancer, it has been found. Those with higher baseline levels of the TNF benefited by taking aspirin.
Source-Medindia
Cost-effectiveness of Ovarian Cancer Therapy Questioned
An analysis conducted by researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is not cost effective.
An analysis conducted by researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is not cost effective.
HBV Infection Lowers Liver Metastasis Risk In Colorectal Cancer Patients
Metastatic liver disease more frequently develops metachronous metastasis following treatment of CRC.
Metastatic liver disease more frequently develops metachronous metastasis following treatment of CRC.
New Device to Identify Tumor Cells
An innovative device to identify and grab circulating tumor cells or CTCs in the blood has been developed by researchers. This key finding plays an important role in cancer metastasis.
An innovative device to identify and grab circulating tumor cells or CTCs in the blood has been developed by researchers. This key finding plays an important role in cancer metastasis.
